肝细胞癌的新辅助免疫疗法的新兴趋势:关注肝移植候选人

Dongdong Yu1, Hao Chen2, Lidong Wang3

  • 1Department of Orthopedic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

PubMed
概括

新辅助免疫疗法对肝移植候选人肝细胞癌 (HCC) 有望,可能改善病期和减少复发. 仔细评估移植器拒绝的风险对于成功的整合至关重要.